Immunotherapy-intensified paraneoplastic dermatomyositis

Indian J Dermatol Venereol Leprol. 2021 Jan-Feb;88(1):93-96. doi: 10.25259/IJDVL_1306_20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Carcinoma, Small Cell / drug therapy
  • Dermatomyositis / etiology*
  • Humans
  • Immune Checkpoint Inhibitors / adverse effects*
  • Lung Neoplasms / drug therapy
  • Male
  • Paraneoplastic Syndromes*

Substances

  • Antibodies, Monoclonal, Humanized
  • Immune Checkpoint Inhibitors
  • atezolizumab